Since CD14brightCD16+ monocytes are abundantly detected in CAD patients (48), it is reasonable to speculate that IL-34 may promote angiogenesis via CD14brightCD16+ monocytes stimulation. This evidence concerns the gene IL34 and coronary artery disorder.